Xavier Scheuermeyer F, Grafstein E, Stenstrom R, Innes G, Poureslami I, Sighary M. Thirty-day outcomes of emergency department patients undergoing electrical cardioversion for atrial brillation or utter. Acad Emerg Med. 2010;17(4):408-415. 273. Jaakkola S, Lip GY, Biancari F, et al. Predicting Unsuccessful Electrical Cardioversion for Acute Atrial Fibrillation (from the AF- CVS Score). Am J Cardiol. 2016. 274. Arnold AZ, Mick MJ, Mazurek RP, Loop FD, Trohman RG. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial brillation or atrial utter. J Am Coll Cardiol. 1992;19(4):851-855. 275. Chalasani P, Cambre S, Silverman ME. Direct-current cardioversion for the conversion of atrial utter. Am J Cardiol. 1996;77(8):658-660. 276. Basili S, Loffredo L, Pastori D, et al. Carotid plaque detection improves the predictive value of CHA2DS2-VASc score in patients with non-valvular atrial brillation: the ARAPACIS Study. Int J Cardiol. 2017;231:143-149. 277. Lip GYH, Collet JP, Haude M, et al. 2018 Joint European consensus document on the management of antithrombotic therapy in atrial brillation patients presenting with acute coronary syndrome and/ or undergoing percutaneous cardiovascular interventions: A joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia- Paci c Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS) and Cardiac Arrhythmia Society of Southern Africa (CASSA) [published online ahead of print July 21, 2018]. Europace. https://doi.org/10.1093/europace/euy174. 278. Bonaca MP, Goto S, Bhatt DL, et al. Prevention of stroke with ticagrelor in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54). (1524-4539 (Electronic)). 279. 